Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Diagn Ther ; 26(6): 627-643, 2022 11.
Article in English | MEDLINE | ID: mdl-36251245

ABSTRACT

Skin wound healing is a crucial process for regenerating healthy skin and avoiding the undesired consequences associated with open skin wounds. For epidermolysis bullosa (EB), a debilitating group of fragile skin disorders currently without a cure, skin blistering can often be severe and heal poorly, increasing susceptibility to life-threatening complications. To prevent these, investigational therapies have been exploring the use of tissue-engineered skin substitutes (TESSs) aimed at replacing damaged skin and promoting long-term wound closure. These products have either been developed in house or commercially sourced and are composed of allogeneic or autologous human skin cells, often with some form of bioscaffolding. They can be broadly classified based on their cellular composition: keratinocytes (epidermal substitutes), fibroblasts (dermal substitutes) or a combination of both (composite substitutes). Encouraging long-term wound healing has been achieved with epidermal substitutes. However, these substitutes have not demonstrated the same efficacy for all patients, which may be due to the molecular heterogeneity observed between EB subtypes. Autologous composite TESSs, which more closely resemble native human skin, are therefore being investigated and may hold promise for treating an extended range of patients. Additionally, future TESSs for EB are focused on using gene-corrected patient skin cells, which have already demonstrated remarkable long-term wound healing capabilities. In this review, we provide an overview of the different TESSs that have been investigated in clinical studies to treat patients with EB, as well as their long-term wound healing results. Where available, we describe the methods used to develop these products to inform future efforts in this field.


Subject(s)
Epidermolysis Bullosa , Skin, Artificial , Humans , Epidermolysis Bullosa/therapy , Keratinocytes , Wound Healing , Skin
2.
Br Dent J ; 225(12): 1057, 2018 12 21.
Article in English | MEDLINE | ID: mdl-30573874
3.
Clin Lab Med ; 30(1): 21-45, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20513540

ABSTRACT

Shiga toxin-producing Escherichia coli (STEC) are important enteric pathogens worldwide, causing diarrhea with or without blood visibly present and hemolytic uremic syndrome. STEC are unique among diarrheogenic E coli in producing Shiga toxin type 1 and type 2, the virulence factors responsible for bloody diarrhea and hemolytic uremic syndrome. Cattle and other ruminants are the natural reservoir of STEC as their normal intestinal flora. Humans become infected by consumption of foods contaminated with cattle feces. Early diagnosis of STEC infection is important because of the contraindication for treating STEC using antimicrobial agents, and the intense supportive care needed if renal failure occurs.


Subject(s)
Escherichia coli Infections/diagnosis , Escherichia coli/isolation & purification , Shiga Toxin/biosynthesis , Diagnosis, Differential , Diarrhea/microbiology , Escherichia coli/classification , Escherichia coli/genetics , Escherichia coli/pathogenicity , Escherichia coli Infections/drug therapy , Escherichia coli Infections/etiology , Escherichia coli Infections/microbiology , Food Microbiology , Humans
4.
Conf Proc IEEE Eng Med Biol Soc ; 2006: 6400-3, 2006.
Article in English | MEDLINE | ID: mdl-17946369

ABSTRACT

We have developed an instrumented pillbox, called a MedTracker, which allows monitoring of medication adherence on a continuous basis. This device improves on existing systems by providing mobility, frequent and automatic data collection, more detailed information about non-adherence and medication errors, and the familiar interface of a 7-day drug store pillbox. We report on the design of the MedTracker, and on the results of a field trial in 39 homes to evaluate the device.


Subject(s)
Drug Monitoring/instrumentation , Patient Compliance , Aged , Aged, 80 and over , Ascorbic Acid/administration & dosage , Computer Communication Networks , Drug Administration Schedule , Drug Monitoring/methods , Electronics , Female , Humans , Male , Microcomputers , Outcome Assessment, Health Care , Self Administration , Tablets/administration & dosage
5.
J Infect Dis ; 191(9): 1530-7, 2005 May 01.
Article in English | MEDLINE | ID: mdl-15809913

ABSTRACT

BACKGROUND: In August 2000, the Minnesota Department of Health was notified of and investigated an outbreak of febrile respiratory illness among workers at a sugar-beet processing plant. METHODS: A case was defined as fever and respiratory symptoms occurring in a worker at the sugar-beet plant on or after 31 July 2000. Case patients were interviewed, medical and work records were reviewed, and clinical samples were obtained. The plant was inspected, and environmental samples were collected. RESULTS: Fourteen of 15 case patients performed high-pressure water cleaning in the confined space of an evaporator vessel. Symptoms included fever and chills (100%), chest tightness (93%), cough (80%), and shortness of breath (73%). In case patients, median temperature was 39.4 degrees C, median oxygen saturation was 93%, and median white blood cell count was 12x10(3) cells/ mu L. Four (29%) of 14 case patients showed evidence of Legionella pneumophila exposure, according to serologic testing. Water sources contained up to 10(5) cfu/mL of L. pneumophila and 22,200 endotoxin units/mL. CONCLUSIONS: Outbreak features were consistent with Pontiac fever. Respiratory symptoms, which are atypical for Pontiac fever, could be attributed to a high exposure dose of L. pneumophila from confined-space aerosolization or to endotoxin exposure. This outbreak demonstrates the potential occupational hazards for those performing high-pressure cleaning in confined spaces.


Subject(s)
Food Industry , Occupational Diseases/epidemiology , Respiratory Distress Syndrome/epidemiology , Environmental Exposure , Fatigue/etiology , Fever/etiology , Food Handling , Humans , Minnesota/epidemiology , Molecular Sequence Data , Sucrose , Water Pollution
6.
J Infect Dis ; 189 Suppl 1: S104-7, 2004 May 01.
Article in English | MEDLINE | ID: mdl-15106098

ABSTRACT

Measles incidence has declined significantly in the United States since the 1989-1991 resurgence. Several conditions, including pockets of underimmunization, international importation, and the inability to rapidly detect and contain cases, represent potential threats to this success. During the 1995-1996 winter holiday season, the Minnesota Department of Health investigated an outbreak of measles among unvaccinated young adults affiliated with a religious community. A total of 26 outbreak-associated cases of measles were identified; most case patients (65%) were 20-29 years of age (range, 18 months to 35 years). Although case patients had multiple opportunities to expose the general public, no subsequent transmission was identified despite extensive surveillance efforts. A measles seroprevalence survey of 508 Minnesota blood donors aged 20-39 years was conducted; 91% had serological evidence of immunity to measles. Our findings illustrate that high levels of population immunity can prevent transmission of measles, despite multiple opportunities for exposure.


Subject(s)
Antibodies, Viral/blood , Disease Outbreaks , Measles virus/immunology , Measles/epidemiology , Religion and Medicine , Vaccination , Adolescent , Adult , Blood Donors , Child , Disease Outbreaks/prevention & control , Humans , Immunoglobulin G/blood , Infant , Male , Measles/immunology , Measles/transmission , Population Surveillance , Seroepidemiologic Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...